drugset / Trial / NCT01794364
Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects
CrossoverDouble-blindBasic science
Summary
The primary purpose of this trial is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of PF-06291874 in healthy volunteers.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06291874 | Small molecule | 75 mg | Oral |
| Subject | PF-06291874 | Small molecule | 500 mg | Oral |
Indications
No indication recorded.